prednisone,cyclophosphamide,rituximab,bendamustine,vincristine,doxorubicin,ibrutinib
janssen,abbvie
['selene', 'lymphoma', 'ibru', 'follicular']
 selene trial #17icml - randomized confirmatory study of ibrutinib plus br or rchop in indolent lymphoma
- placebo controlled
- mostly follicular lymphoma (86%)
- 2/3 prior anthracycline so most received br in selene 
haematology registrar | @harvardmed fellow @PORTAL_research | evidence-based medicine & policy | lymphoma | myeloma | Fulbright | writer | SoMe Ed @BrJHaem